Article
CXCR4-targeted liposomal mediated co-delivery of pirfenidone and AMD3100 for the treatment…
International Journal of Nanomedicine · 2019 · Ullah A, Wang K, Wu P, Oupicky D, Sun M
Key facts
| Title | CXCR4-targeted liposomal mediated co-delivery of pirfenidone and AMD3100 for the treatment of TGFβ-induced HSC-T6 cells activation |
|---|---|
| First author | Ullah A, Wang K, Wu P, Oupicky D, Sun M |
| Journal | International Journal of Nanomedicine |
| Published | Apr 26, 2019 |
| DOI | 10.2147/IJN.S171280 |
| Product codes mentioned | JJQ, JQW, KIP, KIT, MVU, NDS, NJT |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1